Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000078003-25-000114
Filing Date
2025-05-05
Accepted
2025-05-05 16:00:34
Documents
96
Period of Report
2025-03-30

Document Format Files

Seq Description Document Type Size
1 10-Q pfe-20250330.htm   iXBRL 10-Q 2176147
2 EX-31.1 pfe-exh311x3302025x10q.htm EX-31.1 9073
3 EX-31.2 pfe-exh312x3302025x10q.htm EX-31.2 9065
4 EX-32.1 pfe-exh321x3302025x10q.htm EX-32.1 4509
5 EX-32.2 pfe-exh322x3302025x10q.htm EX-32.2 4490
  Complete submission text file 0000078003-25-000114.txt   12463434

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20250330.xsd EX-101.SCH 82747
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20250330_cal.xml EX-101.CAL 157627
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20250330_def.xml EX-101.DEF 412255
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20250330_lab.xml EX-101.LAB 895675
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20250330_pre.xml EX-101.PRE 648516
99 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20250330_htm.xml XML 2366315
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-03619 | Film No.: 25912745
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)